Schedule 13G ownership disclosure

Akebia Therapeutics Inc

Security class unavailable · CUSIP: 00972D105

Event date: 2021-07-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
711
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-21-000380
Form type
SC 13G/A
Filer
Akebia Therapeutics, Inc.
CIK
CIK 1517022
Filed
Aug 10, 2021
Reporting period
Jul 30, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub